Canonical text (the exact bytes fingerprinted)

TRUVACE RECORD VERSION
record: TRV-2026-0890
version: 1
kind: certified
reason: Certified into the record
timestamp: 2026-08-26T06:04:58.048532Z
status: published
lens: g_space
sector: health
headline: Tissue-Agnostic Cellular Morphometric Biomarkers for Risk-Adapted Management Across Gastrointestinal Precancerous Lesions and Cancers
dek: While precision oncology increasingly adopts tissue-agnostic paradigms, current strategies remain heavily reliant on molecular alterations, with limited relevance to early-stage cancers and precancerous lesion management. Here we present an unsupervised and interpretable artificial intelligence framework that defines tissue-agnostic cellular morphometric biomarkers (CMBs) capturing conserved tumor microenvironment (TME) architectures associated with cancer progression across gastrointestinal (GI) organs. Discove…
gain_title: An unsupervised AI framework discovered a 13-marker cellular morphometric signature from colorectal whole-slide images that transferred to gastric and esophageal cancers and enabled risk stratification of precancerous lesions and early-stage cancers to guide surveillance and intervention.
problem_title: (none)
trace_subject: (none)
gain_reading: An unsupervised AI framework discovered a 13-marker cellular morphometric signature from colorectal whole-slide images that transferred to gastric and esophageal cancers and enabled risk stratification of precancerous lesions and early-stage cancers to guide surveillance and intervention.
gain_evidence: The CMB-based risk scores support risk-adapted management, including individualized surveillance intervals and tailored intervention strategies
problem_reading: (none)
problem_evidence: (none)
quick_read: Researchers developed an unsupervised, interpretable AI framework to define tissue-agnostic cellular morphometric biomarkers that capture conserved tumor microenvironment organization across gastrointestinal organs. Discovered in colorectal cancer slides and validated in gastric and esophageal cancers in a 2,602-patient multi-center cohort, a 13-marker signature showed prognostic value and enabled risk stratification of precancerous lesions and early-stage cancers.

The ability to stratify precancerous and early-stage lesions using routine histology could shift management toward individualized surveillance intervals and tailored interventions without relying solely on molecular testing. Remaining questions include prospective clinical utility, generalizability beyond the studied GI sites and centers, and integration into pathology workflows.
limitation: 
tag: Evidence-backed gain
key_points: Unsupervised and interpretable AI framework defined tissue-agnostic cellular morphometric biomarkers capturing conserved tumor microenvironment architectures. | Discovery from colorectal cancer whole-slide images, validated in gastric and esophageal malignancies in multi-center cohort of 2,602 patients. | Integrative bulk and single-cell RNA sequencing and immunohistochemistry showed CMBs correspond to immune-excluded and stromal-dominant architectures.
rundown: The study used colorectal cancer whole-slide images for discovery and extended validation to gastric and esophageal malignancies, reporting a 13-CMB signature with cross-GI transferability in 2,602 patients across multiple centers.

Authors position the approach as addressing an unmet need where molecular profiling is often impractical for early-stage disease, linking morphometric patterns to biologically interpretable TME states via RNA sequencing and immunohistochemistry.
sources:
- peer_reviewed | Advanced Science | https://doi.org/10.1002/advs.77353 | 2026-08-25
prev: 0000000000000000000000000000000000000000000000000000000000000000

sha256

d4fa5a873ad46fb5f16de8e91fbd9cbe696da4f97684514fc07cd4219515e000

previous

0000000000000000000000000000000000000000000000000000000000000000